March 13 (Reuters) - Sino Biopharmaceutical Ltd:
* FY profit attributable to equity holders HK$1.91 billion,
7.6% higher
* FY revenue HK$ 15.83 billion versus HK$14.55 billion
* Company recommended payment of a final dividend of HK1.5
cents per share for year ended 31 December, 2016
Source text for Eikon:
Further company coverage: